Medindia
Medindia LOGIN REGISTER
Advertisement

Tikcro Technologies Announces 2017 Annual General Meeting

Thursday, November 30, 2017 General News
Advertisement
TEL AVIV, Israel, Nov. 30, 2017 /PRNewswire/ -- Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders will be held on January 4, 2018 at 9:30 a.m. Israel time, at the office of the Company at 7 Sapir Street, Ness Ziona, Israel.
Advertisement

The agenda of the meeting is as follows:

(1)   election of Izhak Tamir and Eric Paneth to the Board of Directors

Advertisement

(2)   reappointment of Kost Forer Gabbay and Kasierer, a member of Ernst & Young Global, as independent auditors; and

(3)   consideration of audited financial statements for the year ended December 31, 2016

Items 1 and 2 require the approval of a simple majority of the shares voted on the matter. Item 3 will not involve a vote of the shareholders.

The record date for the meeting is December 5, 2017. Tikcro will send its shareholders of record a proxy statement describing the various matters to be voted upon at the meeting, along with a proxy card enabling them to indicate their vote on each matter.

About Tikcro Technologies:Tikcro Technologies Ltd. (OTCQB: TIKRF) supports early stage development in growth areas, with a focus on biotechnology projects originated in Israeli academic centers. Tikcro is engaged with development of certain antibodies selected and verified in pre-clinical trials with a focus on antibodies targeting immune modulator pathways for cancer treatment. For more information, visit Tikcro's website at www.tikcro.com.

View original content:http://www.prnewswire.com/news-releases/tikcro-technologies-announces-2017-annual-general-meeting-300564586.html

SOURCE Tikcro Technologies Ltd.

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close